Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.74)
# 735
Out of 5,240 analysts
150
Total ratings
54.79%
Success rate
5.9%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PACS PACS Group | Maintains: Outperform | $42 → $48 | $39.65 | +21.06% | 5 | May 13, 2026 | |
| GRDN Guardian Pharmacy Services | Maintains: Outperform | $38 → $43 | $36.27 | +18.56% | 3 | May 7, 2026 | |
| CNC Centene | Maintains: Outperform | $45 → $58 | $58.70 | -1.19% | 20 | Apr 29, 2026 | |
| HCA HCA Healthcare | Maintains: Outperform | $540 → $520 | $432.70 | +20.18% | 14 | Apr 27, 2026 | |
| UNH UnitedHealth Group | Maintains: Outperform | $385 → $405 | $399.09 | +1.48% | 19 | Apr 22, 2026 | |
| TDOC Teladoc Health | Maintains: Outperform | $12 → $7 | $6.61 | +5.90% | 12 | Mar 3, 2026 | |
| EVH Evolent Health | Maintains: Outperform | $12 → $6 | $4.10 | +46.34% | 2 | Mar 2, 2026 | |
| CHE Chemed | Maintains: Outperform | $580 → $500 | $426.21 | +17.31% | 14 | Feb 27, 2026 | |
| EHAB Enhabit | Upgrades: Outperform | $14 | $13.80 | +1.45% | 3 | Jan 22, 2026 | |
| HUM Humana | Maintains: Outperform | $300 → $310 | $301.35 | +2.87% | 13 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $400 → $375 | $294.93 | +27.15% | 11 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $34 → $37 | $36.90 | +0.27% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $165 → $168 | $179.26 | -6.28% | 8 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $140 → $145 | $92.41 | +56.91% | 10 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $2.90 | +72.41% | 10 | Jul 25, 2024 |
PACS Group
May 13, 2026
Maintains: Outperform
Price Target: $42 → $48
Current: $39.65
Upside: +21.06%
Guardian Pharmacy Services
May 7, 2026
Maintains: Outperform
Price Target: $38 → $43
Current: $36.27
Upside: +18.56%
Centene
Apr 29, 2026
Maintains: Outperform
Price Target: $45 → $58
Current: $58.70
Upside: -1.19%
HCA Healthcare
Apr 27, 2026
Maintains: Outperform
Price Target: $540 → $520
Current: $432.70
Upside: +20.18%
UnitedHealth Group
Apr 22, 2026
Maintains: Outperform
Price Target: $385 → $405
Current: $399.09
Upside: +1.48%
Teladoc Health
Mar 3, 2026
Maintains: Outperform
Price Target: $12 → $7
Current: $6.61
Upside: +5.90%
Evolent Health
Mar 2, 2026
Maintains: Outperform
Price Target: $12 → $6
Current: $4.10
Upside: +46.34%
Chemed
Feb 27, 2026
Maintains: Outperform
Price Target: $580 → $500
Current: $426.21
Upside: +17.31%
Enhabit
Jan 22, 2026
Upgrades: Outperform
Price Target: $14
Current: $13.80
Upside: +1.45%
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300 → $310
Current: $301.35
Upside: +2.87%
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $294.93
Upside: +27.15%
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $36.90
Upside: +0.27%
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $179.26
Upside: -6.28%
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $92.41
Upside: +56.91%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $2.90
Upside: +72.41%